Mouse Models of Human Cancers Consortium Workshop on Nervous System Tumors

David H Gutmann1, Elizabeth A Maher, Terry Van Dyke

  • 1Department of Neurology, Washington University School of Medicine, St. Louis, Missouri 63110, USA. gutmannd@neuro.wustl.edu

Cancer Research
|January 7, 2006
PubMed

Insights

Small-animal brain tumor models are advancing our understanding of nervous system tumors. These models are crucial for identifying and testing new therapies to improve patient survival in clinical trials.

Area of Science:

  • Neuro-oncology
  • Translational Cancer Research

Background:

  • Nervous system tumors, including primary brain tumors, present significant clinical challenges with limited improvements in patient survival.
  • Despite numerous clinical trials, effective treatments for brain tumors remain elusive.

Framework:

  • Advancements in small-animal spontaneous brain tumor models, neuroimaging, and bioinformatics have enhanced understanding of human brain tumor pathogenesis.
  • These sophisticated models are pivotal for basic science research and the identification of novel therapeutic targets.

Implementation:

  • Small-animal models are instrumental in validating potential brain tumor therapies.
  • These models facilitate the rigorous evaluation of drug efficacy in preclinical settings.

Implications:

  • The National Cancer Institute convened a workshop to assess current small-animal brain tumor models and their clinical application.
  • Recommendations focus on optimizing the use of mouse models for preclinical evaluation to improve clinical outcomes for brain tumor patients.